Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 1, 2020

View Archived Issues

City of Hope begins phase I study of 64Cu-DOTA-alendronate PET imaging of breast calcifications

Novartis opens phase II trial of CMK-389 for chronic pulmonary sarcoidosis

Field Trip Psychedelics successfully completes GLP synthesis of its preclinical candidate, FT-104

BCX-9930 shows clinical benefit as monotherapy in treatment-naive patients with PNH

Roche and Genentech present lipoprotein signal peptidase inhibitors

Mcl-1 inhibitors patented by Zeno Management

University of Texas, University of Arkansas discover GRB2 inhibitors

Translational Genomics Research Institute discloses CDK7 inhibitors

Propella Therapeutics presents new abiraterone prodrugs

Bacterial/viral combination is linked to postinfectious hydrocephalus

Creative Medical Technology reports preclinical data on ImmCelz in rheumatoid arthritis model

Positive topline data presented from ILLUMINATE-B phase III study of lumasiran

First patients dosed in phase IIa study of COVID-19 vaccine candidate, CVnCoV

MedinCell begins the first study of its COVID-19 prevention program

Myozenin-1 levels increase to ameliorate diabetic sarcopenia

Eisai initiates MOMENTUM 1 study of lorcaserin in Dravet syndrome

Allergan withdraws uterine fibroid drug Fibristal from Canadian market

Reduction in CNS recurrence for adjuvant osimertinib in NSCLC

Intellia presents preclinical data on CRISPR/Cas9 platform

Phase I/IIa extension data with arfolitixorin show 55% ORR in metastatic colorectal cancer

First-in-human data for camidanlumab tesirine in advanced solid tumors

ARCADE and ENDYMION results with soticlestat show seizure frequency reduction in rare epilepsies

Galapagos begins patient dosing with GLPG-3970 in psoriasis

Phase III study clearance in China for eftansomatropin in pediatric growth hormone deficiency

Enlivex reports data on use of Allocetra in COVID-19 patients in severe or critical condition

Codiak initiates phase I/II study of exoSTING for solid tumors

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.